MacroGenics
MGNX
#8794
Rank
HK$1.86 B
Marketcap
HK$29.35
Share price
5.35%
Change (1 day)
123.15%
Change (1 year)

MacroGenics (MGNX) - Cash on Hand

Cash on Hand as of June 2026 : HK$1.35 Billion

According to MacroGenics's latest financial reports the company has HK$1.35 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

MacroGenics - Cash on Hand chart (from 2012 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$1.47 B-5.62%
2024-12-31HK$1.56 B-12.77%
2023-12-31HK$1.79 B48.83%
2022-12-31HK$1.20 B-36.52%
2021-12-31HK$1.89 B-10.09%
2020-12-31HK$2.11 B25.73%
2019-12-31HK$1.68 B-7.85%
2018-12-31HK$1.82 B-23.51%
2017-12-31HK$2.38 B10.98%
2016-12-31HK$2.14 B-18.26%
2015-12-31HK$2.62 B114.99%
2014-12-31HK$1.22 B35.33%
2013-12-31HK$0.90 B144.07%
2012-12-31HK$0.37 B-13.71%
2011-12-31HK$0.42 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
HK$91.79 B 6,649.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$70.23 B 5,064.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$109.77 B 7,971.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$24.94 B 1,734.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$56.03 B 4,020.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$86.84 B 6,285.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$3.58 B 163.38%๐Ÿ‡บ๐Ÿ‡ธ USA